A dedicated supporter of Dana-Farber Cancer Institute for more than 28 years, Expect Miracles Foundation marked a record-breaking year in 2022 by raising $1.25 million in support of the Robert and Renée Belfer Center for Applied Cancer Science at Dana-Farber. To date, the foundation has donated a cumulative total of more than $13 million to Dana-Farber in its quest to generate hope and improve outcomes for cancer patients.
Expect Miracles Foundation rallies members of the financial services industry and beyond to invest in cancer research—from leading financial services companies to start-ups, senior executives to young adults, and corporate foundations to family trusts. In addition to funding research, the organization aims to advance the financial and emotional health of young adult cancer survivors through its financial assistance Samfund grants program.
Funds are raised through a variety of events each year. In 2022, this included fitness fundraisers, networking events, and two signature golf tournaments. Financial industry executives came together at the foundation’s longest-standing event, the 28th Annual East Coast Classic golf tournament in July, which was held at the Pinehills Golf Course in Plymouth, Mass. In October, despite an overcast, rainy day, over 330 golfers were determined to putt for a purpose, joining Expect Miracles Foundation at the Fiddler’s Elbow Country Club in Bedminster, N.J., for the foundation’s largest tournament to date: the 5th Annual Atlantic Coast Classic.
“I am immensely proud that Expect Miracles Foundation is one of the top 75 donors of Dana-Farber since it was founded in 1947 and want to express my gratitude to our supporters whose steadfast generosity led to us achieving a fundraising record in 2022,” said Frank Strauss, founder and chairman of Expect Miracles Foundation. “Together, we are fueling revolutionary research at Dana-Farber Cancer Institute that will have a lifesaving impact.”
All funds raised for Dana-Farber benefit the Belfer Center, a fully integrated oncology research center where academic physician-scientists collaborate with leading pharmaceutical companies to drive the development of next-generation cancer therapies.
“Support from Expect Miracles Foundation has propelled our progress,” said Pasi Jänne, MD, PhD, director of the Belfer Center and of the Carole M. and Philip L. Lowe Center for Thoracic Oncology and the Chen-Huang Center for EGFR Mutant Lung Cancers. Jänne is also the David M. Livingston, MD, Chair at Dana-Farber. “The funding allows investigators to efficiently tackle challenges in clinical research and drug development, improving how we detect, treat, and defy cancer.”
For more stories about the impact of philanthropy at Dana-Farber, please visit DanaFarberImpact.org.